Krsnaa Diagnostics
NSE: KRSNAA · ISIN INE08LI01020 · Healthcare
₹490.90+5.55 (+1.14%)
Monday 9 November, 12:47 IST. Delayed. Source: Yahoo Finance.
Price chart
₹490.90 +5.55 (+1.14%) today
The day
- Previous close
- ₹485.35
- Open
- ₹492.90
- Day high
- ₹492.90
- Day low
- ₹483.00
Listed on NSE since 16 August 2021.
Key numbers
- Market value
- ₹1,653.09 Cr
- P/E (trailing)
- 16.22
- EPS (trailing)
- ₹29.93
- Price to book
- 1.61
- Dividend yield
- 0.40%
- Debt to equity
- 0.55
- Profit margin
- 11.6%
- Beta
- 0.08
- Volume today
- 23,394
- Average volume
- 1.26 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹487.12 Cr | ₹62.11 Cr |
| FY24 | ₹619.63 Cr | ₹56.84 Cr |
| FY25 | ₹717.16 Cr | ₹77.61 Cr |
| FY26 | ₹772.77 Cr | ₹101.43 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹271 Cr | ₹25 Cr | +2.7% |
| Q1 FY27Apr–Jun 2026 | ₹236 Cr | ₹17 Cr | −19.3% |
| Q4 FY26Jan–Mar 2026Audited | ₹193 Cr | ₹42 Cr | +101.8% |
| Q3 FY26Oct–Dec 2025 | ₹181 Cr | ₹0 | – |
| Q2 FY26Jul–Sep 2025 | ₹206 Cr | ₹24 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹193 Cr | ₹21 Cr | – |
Source: Krsnaa Diagnostics’s results filed with NSE, consolidated (the whole group). Net profit is the share of Krsnaa Diagnostics’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹854 Cr | ₹860 Cr |
| Investments | ₹57 Cr | ₹57 Cr |
| Inventories | ₹33 Cr | ₹27 Cr |
| Owed by customers | ₹475 Cr | ₹296 Cr |
| Cash and equivalents | ₹77 Cr | ₹30 Cr |
| Total assets | ₹2,064 Cr | ₹1,824 Cr |
| Borrowings | ₹596 Cr | ₹534 Cr |
| Total liabilities | ₹1,025 Cr | ₹843 Cr |
| Shareholders’ equity | ₹1,039 Cr | ₹980 Cr |
Source: Krsnaa Diagnostics’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Krsnaa Diagnostics
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers mammography, stress tests, dual-energy X-ray absorptiometry scans, bone mineral density tests, computed tomography scans, and magnetic resonance imaging services, as well as tele-radiology and tele-pathology services. The company was incorporated in 2010 and is based in Pune, India.
- Industry
- Diagnostics & Research
- Based in
- Pune
- Employees
- 3,296
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Krsnaa Diagnostics in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 2 Per Share
Dividend · ex-date 18 September 2026
- Dividend - Rs 2.75 Per Share
Dividend · ex-date 12 September 2025
- Annual General Meeting
Action · ex-date 13 September 2024
- Dividend - Rs 2.50 Per Share
Dividend · ex-date 13 September 2024
- Dividend - Rs 2.75 Per Share
Dividend · ex-date 15 September 2023
- Annual General Meeting
Action · ex-date 15 September 2023
- Dividend - Rs 2.50 Per Share
Dividend · ex-date 15 September 2022 · record date 16 September 2022
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.